The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.
Microbial Contributions to Brain Function
Gut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as serotonin and gamma-aminobutyric acid (GABA), as well as short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate. These metabolites can influence brain activity by modulating neural signaling, reducing inflammation, and preserving the integrity of the blood–brain barrier.
Microbiome Development in Early Life
The gut is rapidly colonized after birth by maternal and environmental microbes. This early microbial exposure plays a key role in shaping the development of the immune system and influencing early brain maturation. By the age of three, the gut microbiome typically stabilizes into a relatively consistent community that supports nutrient absorption, immune balance, and physiological homeostasis.
Homeostasis and Brain Support
A well-balanced gut microbiome helps maintain systemic equilibrium by regulating inflammation, reinforcing the blood–brain barrier, and influencing the development and function of brain glial cells, especially microglia. These cells are critical for immune surveillance and neural maintenance within the central nervous system.
Dysbiosis and Neurological Impacts
A disruption in the microbial balance—known as dysbiosis—can impair these regulatory functions. It may lead to chronic inflammation and produce harmful metabolic byproducts that negatively affect brain development and function. Dysbiosis has been associated with several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder.
Experimental Insights from Animal Studies
Animal studies have shown that dysbiosis-associated compounds, such as 4-ethylphenylsulfate, can induce anxiety-like and repetitive behaviors. Conversely, restoring microbial balance using beneficial bacteria like Bacteroides fragilis has been shown to normalize metabolite levels and reverse these behavioral abnormalities.
The gut–brain axis is a two-way communication system linking the gut and brain via host-derived signals from neurons and immune cells, as well as microbial metabolites produced in the gut.
After birth, maternal and environmental microbes rapidly colonize the gut. Research suggests this early colonization may be linked to immune and some aspects of neural development.
By three years of age, the gut microbiome stabilizes, supporting nutrient absorption and maintaining physical and chemical homeostasis.
Additionally, the gut microbiome can produce immune-modulating metabolites like tryptophan derivatives, which enter the bloodstream and help support the blood–brain barrier’s structure and function.
Microbial imbalance, or dysbiosis, can alter the production of these metabolites and may weaken blood–brain barrier integrity, affecting gut–brain communication.
In mouse models, dysbiosis-associated compounds such as 4-ethylphenylsulfate have been shown to trigger anxiety-like behaviors.
Specific probiotics, like Bacteroides fragilis, can restore microbial balance and reverse these effects.
繁體中文
